Effect of rutin on cytarabine-associated pulmonary oedema and oxidative stress in rats
Özet
Cytarabine is effectively used in the treatment of adult acute leukemia, but it has a dose-limiting side effect of fatal pulmonary oedema because it increases the vascular permeability of the alveolar capillaries. The aim of the present study was to conduct a radiological, biochemical and histopathological investigation of the effect of rutin on cytarabine-associated pulmonary oedema in rats. Rats were treated with a combination of rutin+cytarabine by administering oral rutin at a dose of 50 mg/kg; other rat groups were orally administered the same volume of physiological saline. One hour after administration of rutin or saline, the rutin+cytarabine and cytarabine groups received an intraperitoneal injection of cytarabine (200 mg/kg). This administration procedure was repeated once a day for 14 days. Radiologically, 50% of the animals given cytarabine alone showed lung oedema, but the rutin+cytarabine group showed no oedema. The inclusion of rutin decreased the amounts of cytarabine-associated malondialdehyde, tumour necrosis factor-α, and nuclear factor-κB in the lung tissue. Rutin also inhibited the reduction of total glutathione by nitric oxide. These findings suggest that rutin may be a beneficial adjunct that can minimise the development of cytarabine-associated pulmonary oedema. © 2020, Academia Brasileira de Ciencias. All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Bilgin, Asli O. | |
| dc.contributor.author | Mammadov, Renad | |
| dc.contributor.author | Suleyman, Bahadir | |
| dc.contributor.author | Unver, Edhem | |
| dc.contributor.author | Ozcicek, Fatih | |
| dc.contributor.author | Soyturk, Mehmet | |
| dc.contributor.author | Cimen, Ferda K. | |
| dc.contributor.author | Kurt, Nezahat | |
| dc.contributor.author | Suleyman, Halis | |
| dc.date.accessioned | 2026-10-18T20:28:22.305483424Z | |
| dc.date.available | 2026-10-18T20:28:22.305483424Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Cytarabine is effectively used in the treatment of adult acute leukemia, but it has a dose-limiting side effect of fatal pulmonary oedema because it increases the vascular permeability of the alveolar capillaries. The aim of the present study was to conduct a radiological, biochemical and histopathological investigation of the effect of rutin on cytarabine-associated pulmonary oedema in rats. Rats were treated with a combination of rutin+cytarabine by administering oral rutin at a dose of 50 mg/kg; other rat groups were orally administered the same volume of physiological saline. One hour after administration of rutin or saline, the rutin+cytarabine and cytarabine groups received an intraperitoneal injection of cytarabine (200 mg/kg). This administration procedure was repeated once a day for 14 days. Radiologically, 50% of the animals given cytarabine alone showed lung oedema, but the rutin+cytarabine group showed no oedema. The inclusion of rutin decreased the amounts of cytarabine-associated malondialdehyde, tumour necrosis factor-α, and nuclear factor-κB in the lung tissue. Rutin also inhibited the reduction of total glutathione by nitric oxide. These findings suggest that rutin may be a beneficial adjunct that can minimise the development of cytarabine-associated pulmonary oedema. © 2020, Academia Brasileira de Ciencias. All rights reserved. | |
| dc.identifier.doi | 10.1590/0001-3765202020190261 | |
| dc.identifier.eissn | 1678-2690 | |
| dc.identifier.endpage | 11 | |
| dc.identifier.issn | 0001-3765 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 32401838 | |
| dc.identifier.scopus | 2-s2.0-85084625940 | |
| dc.identifier.startpage | 1 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/13539 | |
| dc.identifier.volume | 92 | |
| dc.identifier.wos | WOS:000535194500001 | |
| dc.language.iso | en | |
| dc.publisher | Academia Brasileira de Ciencias | |
| dc.relation.ispartof | Anais da Academia Brasileira de Ciencias | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Cytarabine | |
| dc.subject | Oxidative stress | |
| dc.subject | Pulmonary oedema | |
| dc.subject | Rutin | |
| dc.subject | Animals | |
| dc.subject | Anti-Inflammatory Agents | |
| dc.subject | Antioxidants | |
| dc.subject | Male | |
| dc.subject | NF-kappa B | |
| dc.subject | Oxidants | |
| dc.subject | Pulmonary Edema | |
| dc.subject | Rats | |
| dc.subject | Rats, Wistar | |
| dc.subject | Tumor Necrosis Factor-alpha | |
| dc.subject | antiinflammatory agent | |
| dc.subject | antioxidant | |
| dc.subject | immunoglobulin enhancer binding protein | |
| dc.subject | oxidizing agent | |
| dc.subject | rutoside | |
| dc.subject | tumor necrosis factor | |
| dc.subject | animal | |
| dc.subject | blood | |
| dc.subject | drug effect | |
| dc.subject | lung edema | |
| dc.subject | pathology | |
| dc.subject | rat | |
| dc.subject | Wistar rat | |
| dc.title | Effect of rutin on cytarabine-associated pulmonary oedema and oxidative stress in rats | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 14 | |
| rdl.citation.wos | 14 | |
| rdl.department | Department of Pharmacology, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Pulmonology, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Internal Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Radiology, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Pathology, Erzincan Binali Yildirim University, Erzincan, Turkey. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
